Discover

GRI
GRI Bio, Inc.
1.74
1 x 2.17
1 x 2.55
bid
ask
+
0.06
3.57%
1 @ 04:00 PM
1.74 +0.00 (0.00%)
Ytd-74.86%
1y-96.85%
1.70
day range
1.76
1.38
52 week range
63.28
Open1.71Prev Close1.68Low1.70High1.76Mkt Cap3.80M
Vol21.34KAvg Vol328.24KEPS-15.32P/EN/AForward P/E-0.29
Beta-1.21Short Ratio0.10Inst. Own4.71%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-1850-d Avg1.87200-d Avg2.741yr Est11.50
Income Statement
Operating Expenses1.65M
Research and Development Expense407.00K
Selling, General and Administrative Expense1.24M
Operating Income-1.65M
Net Income-1.64M
Net Income Common Stock-1.64M
Net Income Common Stock (USD)-1.64M
Consolidated Income-1.64M
Earnings per Basic Share-0.91
Earnings per Basic Share (USD)-0.91
Earnings per Diluted Share-0.91
Earning Before Interest & Taxes (EBIT)-1.64M
Earning Before Interest & Taxes (USD)-1.64M
Weighted Average Shares1.80M
Weighted Average Shares Diluted1.80M
Balance Sheet
Cash and Equivalents10.95M
Cash and Equivalents (USD)10.95M
Current Assets11.33M
Property, Plant & Equipment Net46.00K
Total Assets11.38M
Debt Current44.00K
Total Debt44.00K
Current Liabilities1.10M
Total Liabilities1.10M
Accumulated Retained Earnings (Deficit)-55.34M
Shareholders Equity10.28M
Shareholders Equity (USD)10.28M
Assets Non-Current46.00K
Total Debt (USD)44.00K
Trade and Non-Trade Payables526.00K
Cash Flow
Net Cash Flow from Financing1.35M
Net Cash Flow / Change in Cash & Cash Equivalents-101.00K
Issuance (Purchase) of Equity Shares1.35M
Net Cash Flow from Operations-1.45M
Share Based Compensation33.00K